Novo Nordisk’s Wegovy (semaglutide) and Eli Lilly’s Zepbound (tirzepatide) quickly reached blockbuster status within their ...

By screening people for eating disorders and disordered eating before these medications are prescribed, we can prevent unintended consequences.

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

Chronic Kidney Disease is a silent killer that progresses gradually, often going unnoticed until the late stages. While ...

GLP1 (Glucagon like peptide-1 ... Imaging: X-rays, CT scans and ultrasound to see the size, shape, location and number of stones. Blood tests: These check your kidney function, detect infections ...

This is an increase of almost 50% since 2018 and suggests deals with big players will continue to shape the clinical ... inhibitory peptide (GIP), GLP-1/glucagon, and GLP-1/amylin.

This year also saw what many believed might never happen – the US gained its own independent cost- and clinical-effectiveness watchdog, in the shape of ... The glucagon-like peptide-1 (GLP ...

Viking Therapeutics' plans to launch VK2735 with an auto-injector could delay regulatory approval. Click here to read why ...

Ozempic, a medication for type 2 diabetes and weight loss, mimics the action of GLP-1 to regulate blood sugar and appetite. Although Ozempic itself isn't found in food, high-fiber and probiotic ...

In this podcast, Motley Fool analyst Karl Thiel joins host Ricky Mulvey to check in on the GLP-1 landscape. They discuss: How weight loss drugs actually work, and how big-name prescriptions differ ...